Greiner Bio-One North America

Executive Summary

Greiner Bio-One North America, a U.S. subsidiary of the global Greiner Bio-One group, is a leading provider of pre-analytical systems and diagnostic products for clinical and life science laboratories. The company offers a comprehensive portfolio including blood collection tubes, needles, and laboratory automation solutions, serving healthcare institutions and research facilities across North America. Operating from its Monroe, North Carolina headquarters, the subsidiary benefits from the parent company's extensive R&D capabilities and manufacturing scale. The North American market remains a critical growth driver for Greiner Bio-One, driven by increasing demand for diagnostic testing, laboratory automation, and safety-engineered medical devices. The subsidiary is well-positioned to capitalize on trends toward decentralized testing and point-of-care diagnostics, though it faces competition from established players like Becton Dickinson and Thermo Fisher. As a private entity, financial performance is not publicly disclosed, but the parent company's commitment to innovation and capacity expansion suggests ongoing investment in the region.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Safety Blood Collection Set70% success
• Q3 2026FDA Clearance for Expanded Pre-Analytical Automation Platform60% success
• Q3 2026Capacity Expansion at Monroe, NC Manufacturing Facility75% success